Your browser doesn't support javascript.
loading
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.
Komrokji, Rami S; Seymour, John F; Roberts, Andrew W; Wadleigh, Martha; To, L Bik; Scherber, Robyn; Turba, Elyce; Dorr, Andrew; Zhu, Joy; Wang, Lixia; Granston, Tanya; Campbell, Mary S; Mesa, Ruben A.
Afiliação
  • Komrokji RS; Moffitt Cancer Center, Tampa, FL;
  • Seymour JF; Peter McCallum Cancer Center, Melbourne, Australia; Sir Peter MacCallum Department of Oncology.
  • Roberts AW; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia; Royal Melbourne Hospital, Melbourne, Australia;
  • Wadleigh M; Dana-Farber Cancer Institute, Boston, MA;
  • To LB; Royal Adelaide Hospital, Adelaide, Australia;
  • Scherber R; Mayo Clinic, Scottsdale, AZ;
  • Turba E; Moffitt Cancer Center, Tampa, FL;
  • Dorr A; Independent Consultant for S*BIO Pte Ltd., Singapore;
  • Zhu J; S*BIO Pte Ltd., Singapore; and.
  • Wang L; CTI BioPharma, Seattle, WA.
  • Granston T; CTI BioPharma, Seattle, WA.
  • Campbell MS; CTI BioPharma, Seattle, WA.
  • Mesa RA; Mayo Clinic, Scottsdale, AZ;
Blood ; 125(17): 2649-55, 2015 Apr 23.
Article em En | MEDLINE | ID: mdl-25762180

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Hidrocarbonetos Aromáticos com Pontes / Tirosina Quinase 3 Semelhante a fms / Janus Quinase 2 / Mielofibrose Primária Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Hidrocarbonetos Aromáticos com Pontes / Tirosina Quinase 3 Semelhante a fms / Janus Quinase 2 / Mielofibrose Primária Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article